Fucoxanthin mitigates inflammation and angiogenesis in rheumatoid arthritis via regulation of the PPAR-γ/CTGF pathway
Allergologia et Immunopathologia · 2025
DOI: 10.15586/aei.v53i6.1425 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergologia et Immunopathologia, 2025. Verfasst von Ximing Zhao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Joint Orthopedics, Qinghai University Affiliated Hospital, Xining City, Qinghai Province 810000, China. Hauptthemen laut MEDLINE: Xanthophylls, Arthritis, Rheumatoid, Neovascularization, Pathologic, PPAR gamma. Gefördert von: None..
Abstract (Originalsprache)
Background
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disorder that causes joint pain and significantly impairs patients’ quality of life. Fucoxanthin, a naturally occurring carotenoid found in seaweeds and diatoms, has been reported to exert various therapeutic effects in multiple pathological conditions. However, its regulatory role in the pathogenesis of RA remains largely undefined.
Methods
Cell viability was assessed using the cell counting kit-8 (CCK-8) assay, while cell migration and invasion were evaluated through the wound healing and Transwell assays, respectively. Angiogenic potential was determined by the tube formation assay. The levels of pro-inflammatory cytokines, including interleukin (IL)-6, IL-1β, and IL-8, were measured using enzyme-linked-immunosorbent serologic assay. Intracellular reactive oxygen species (ROS) levels were analyzed via DCFH-DA staining, and protein expression was evaluated by Western blot analysis.
Results
Fucoxanthin significantly suppressed tumor necrosis factor-α (TNF-α)-induced proliferation of MH7A synovial cells. Additionally, TNF-α stimulation enhanced cell migration and invasion, whereas these effects were reversed with fucoxanthin treatment. TNF-α also promoted angiogenesis, as evidenced by an increased number of tube formations, which were markedly reduced by fucoxanthin in a dose-dependent manner (control; TNF-α; TNF-α + fucoxanthin [2 μM]; and TNF-α + fucoxanthin [4 μM], with respective values of 1.33 ± 0.58; 26 ± 3.61; 17 ± 2.65; and 8.33 ± 1.53; P < 0.001). Moreover, fucoxanthin alleviated TNF-α-induced inflammatory cytokine release and oxidative stress. Mechanistically, fucoxanthin was found to regulate the PPAR-γ/CTGF signaling pathway.
Conclusion
Fucoxanthin may attenuate inflammation and angiogenesis in RA by modulating the PPAR-γ/CTGF pathway, suggesting its potential as a therapeutic agent for managing RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Joint Orthopedics, Qinghai University Affiliated Hospital, Xining City, Qinghai Province 810000, China.
- Department of Corneal Ocular Surface, Qinghai Aier Eye Hospital, Xining City, Qinghai Province 810000, China; xinglzhou0230@163.com.
Förderung
- None.
Zitieren
APA
Zhao, X., Zhou, X., & Li, F. (2025). Fucoxanthin mitigates inflammation and angiogenesis in rheumatoid arthritis via regulation of the PPAR-γ/CTGF pathway. Allergologia et Immunopathologia. https://doi.org/10.15586/aei.v53i6.1425
Vancouver
Zhao X, Zhou X, Li F. Fucoxanthin mitigates inflammation and angiogenesis in rheumatoid arthritis via regulation of the PPAR-γ/CTGF pathway. Allergologia et Immunopathologia. 2025. doi:10.15586/aei.v53i6.1425
BibTeX
@article{Zhao2025,
author = {Zhao, Ximing and Zhou, Xingli and Li, Famin},
title = {Fucoxanthin mitigates inflammation and angiogenesis in rheumatoid arthritis via regulation of the PPAR-γ/CTGF pathway},
journal = {Allergologia et Immunopathologia},
year = {2025},
doi = {10.15586/aei.v53i6.1425}
}
EUVIMED